IRIS
ORDITURA, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.011
NA - Nord America 8.022
AS - Asia 5.123
SA - Sud America 830
Continente sconosciuto - Info sul continente non disponibili 553
AF - Africa 86
OC - Oceania 13
Totale 27.638
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 7.860
US - Stati Uniti d'America 7.790
SG - Singapore 1.710
IE - Irlanda 1.382
CN - Cina 1.093
IT - Italia 1.083
HK - Hong Kong 810
BR - Brasile 685
UA - Ucraina 635
VN - Vietnam 601
GB - Regno Unito 540
DE - Germania 501
FR - Francia 353
KR - Corea 334
FI - Finlandia 188
SE - Svezia 151
CA - Canada 139
IN - India 130
GR - Grecia 121
TR - Turchia 106
JP - Giappone 88
BD - Bangladesh 85
AR - Argentina 49
PL - Polonia 36
MX - Messico 35
ID - Indonesia 33
NL - Olanda 33
IQ - Iraq 27
AT - Austria 26
EC - Ecuador 24
ZA - Sudafrica 19
CO - Colombia 18
VE - Venezuela 17
BE - Belgio 16
ES - Italia 16
MA - Marocco 16
SC - Seychelles 13
CL - Cile 12
CZ - Repubblica Ceca 11
PK - Pakistan 11
CR - Costa Rica 10
AL - Albania 9
HN - Honduras 9
LT - Lituania 9
SA - Arabia Saudita 9
TN - Tunisia 9
JM - Giamaica 8
NP - Nepal 8
PE - Perù 8
AE - Emirati Arabi Uniti 7
DK - Danimarca 7
EG - Egitto 7
IL - Israele 7
KE - Kenya 7
NZ - Nuova Zelanda 7
PH - Filippine 7
PY - Paraguay 7
AU - Australia 6
EE - Estonia 6
EU - Europa 6
IR - Iran 6
MY - Malesia 6
TH - Thailandia 6
UZ - Uzbekistan 6
BH - Bahrain 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
JO - Giordania 5
RO - Romania 5
TT - Trinidad e Tobago 5
GT - Guatemala 4
LB - Libano 4
PT - Portogallo 4
SN - Senegal 4
SV - El Salvador 4
UY - Uruguay 4
CH - Svizzera 3
ET - Etiopia 3
KG - Kirghizistan 3
LU - Lussemburgo 3
AG - Antigua e Barbuda 2
AO - Angola 2
AZ - Azerbaigian 2
CG - Congo 2
CY - Cipro 2
DZ - Algeria 2
HU - Ungheria 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
RS - Serbia 2
SI - Slovenia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
Totale 27.075
Salva come PNG Salva come JPEG
Città #
Moscow 2.854
Dublin 1.369
San Jose 1.091
Jacksonville 936
Hong Kong 800
Santa Clara 773
Singapore 685
Chandler 643
Ashburn 562
Council Bluffs 431
Seoul 310
Princeton 195
Ho Chi Minh City 189
Medford 171
New York 158
Milan 146
Hanoi 137
Beijing 134
Caserta 129
Bremen 122
Hefei 119
Roxbury 118
Naples 115
Ann Arbor 107
Boardman 105
San Mateo 94
Bengaluru 87
Munich 85
Wilmington 75
Los Angeles 71
Dallas 66
Woodbridge 61
São Paulo 60
The Dalles 53
Elora 52
Nanjing 49
Des Moines 46
Dong Ket 36
Napoli 36
Cambridge 34
Nuremberg 34
Haiphong 33
Jinan 32
Miano 32
Rome 32
Kraków 29
Houston 28
Da Nang 26
Atlanta 24
Rio de Janeiro 24
Toronto 22
Helsinki 21
Mountain View 21
Chicago 20
Tokyo 18
Turku 18
Changsha 17
Norwalk 17
Shanghai 17
Tianjin 17
Vienna 16
Amsterdam 15
Brussels 15
Curitiba 15
Aiello Del Sabato 14
Memphis 14
Nanchang 14
Orem 14
Shenyang 14
Belo Horizonte 13
Hangzhou 13
Biên Hòa 12
Frankfurt am Main 12
Guangzhou 12
Montreal 12
Porto Alegre 12
Brasília 11
Chennai 11
Ottawa 11
Zhengzhou 11
Auburn Hills 10
Aversa 10
Brno 10
Buffalo 10
Campinas 10
Guarulhos 10
Hải Dương 10
Johannesburg 10
Mexico City 10
Newark 10
Seattle 10
Taizhou 10
Thái Bình 10
Thái Nguyên 10
Baghdad 9
Bari 9
Columbus 9
Düsseldorf 9
Istanbul 9
Jakarta 9
Totale 14.241
Salva come PNG Salva come JPEG
Nome #
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 320
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 221
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy. 218
ONCOLOGIA MEDICA 215
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial 205
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients 203
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 200
Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis 198
Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma—a pilot study. Curr Oncol 21, 3, june 2014 125-133 198
Adjuvant chemoradiotherapy in patients with stage III-IV radically resected gastric cancer: a pilot study 195
A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC). 191
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer 190
Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: A propensity score-matched analysis 190
Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis 189
Naples Prognostic Score, Based on Nutritional and Inflammatory Status, is an Independent Predictor of Long-term Outcome in Patients Undergoing Surgery for Colorectal Cancer 186
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors 186
Amifostine: a selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review) 185
Cancer Treatment–Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy 184
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) 183
CD 26-positive/CD 326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence 181
Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience 180
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. 177
Clinical management of advanced gastric cancer: Role of new molecular drugs. 176
Different Biomarkers address different colorectal cancer stem cell populations: who's the killer? 172
Indocyanine Green Fluorescence Imaging-Guided Surgery in Primary and Metastatic Liver Tumors 172
Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the Covid-19 Pandemic 172
Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. 171
Mixed Neuroendocrine Non-Neuroendocrine Neoplasms of the Gastrointestinal Tract: A Case Series 171
Pancreatic fistula following pancreatoduodenectomy. Evaluation of different surgical approaches in the management of pancreatic stump. Literature review. 170
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival 170
A true splenic cyst producing carbohydrate antigen 19-9 and cancer antigens 50 and 125, but not interleukin 10 169
Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer. 169
Behavior of circulating CD4+CD25+FOXP3* regulatory T cells in colon cancer patients undergoing surgery 169
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 169
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment 168
Post-Irradiation Breast Angiosarcoma: All the Possible Treatments and Electrochemotherapy. Case Report and Literature Review 166
Treatment of gastric cancer. 165
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer 162
Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review. 161
Conversion chemotherapy followed by epatic resection in colorectal cancer with initially unresectable liver-limited metastases 161
Adult Wilms' tumor: a case report 158
Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score. 158
Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome 156
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer 156
HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study 155
Fluorescence-Guided Surgery in the Combined Treatment of Peritoneal Carcinomatosis from Colorectal Cancer: Preliminary Results and Considerations 155
Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion 154
Beyond Platinum, ICIs in Metastatic Cervical Cancer: A Systematic Review 153
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors 153
Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: a propensity score-matched analysis 153
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: a single institution retrospective analysis 153
Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers ? A prospective study. 153
Regorafenib beyond the Second Line in Relapsed Glioblastoma: A Case Report and Literature Review 151
Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: A randomised study by the Southern Italy Cooperative Oncology Group 151
The over-the-scope-clip (OTSC) system is effective in the treatment of chronic esophago-jejunal anastomotic leakage 151
Preoperative Neutrophil to Lymphocyte Ratio and Lymphocyte to Monocyte Ratio are Prognostic Factors in Gastric Cancers Undergoing Surgery 151
Farmacogenomica e cancro colorettale 148
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs 148
Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types 147
Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass 147
Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs 147
Analysis of recovery time indexes in 5-fluorouracil-treated cancer patients 146
Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells 144
Atypycal presentation of Merkel cell carcinoma positive to polyomavirus DNA detection: experience from a single center 144
Adjuvant chemotherapy of gastric cancer: which regimen? 142
Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies 142
Serum interleukin-10 is an independent prognostic factor in advanced solid tumors 142
p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate 142
Immune-Based Therapy in Triple-Negative Breast Cancer: From Molecular Biology to Clinical Practice 141
Complete response to preoperative chemoradiation and survival in esophageal cancer : a pooled analysis of three singe-institution phase II trials. 141
TRASTUZUMAB RESISTANCE IN BREAST CANCER 141
An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer 141
Increased circulating levels of vascular endothelial growth factor C can predict outcome in resectable gastric cancer patients 140
The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery. 139
Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report. 139
Cardiotossicità da antracicline: attualità e prospettive 139
Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation 138
Serum vascular endothelial growth factor (VEGF)levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer 137
Chemoradiotherapy as adjuvant treatment of gastric cancer 137
Integrated therapy in localized gastric cancer: targeted and tailored approach. 136
Il linfoma primitivo della parotide: una localizzazione infrequente 136
Phosphatidylinositol 3-kinase (PI3Ka)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells 136
Propensity score-matched comparison between complete mesocolic excision and classic right hemicolectomy for colon cancer 136
Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions 136
Determination of molecular marker expression can predict clinical outcome in colon carcinomas 135
Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracyclina-induced cardiotoxicity (review) 135
Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis 135
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next generation sequencing: findings from the CAPRI-GOIM trial. 133
NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): From clinical trials to clinical practice 133
Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery 132
Capecitabine plus weekly oxaliplatin in gastrointestinal tumors. A phase I study 132
Post- operative xelox and chemoradiation in stage III-IV radically resected gastric cancer patients: preliminary results of a pilot study. 132
Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery 131
A pilot study of adjuvant chemotherapy with double modulation of 5-fluorouracil by methotrexate and leucovorin in gastric cancer patients. 131
Targeting EGFR in Pancreatic Cancer Treatment. 131
Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator 130
Postoperative detection of circulating tumor cells predicts tumor recurrence in colorectal cancer patients 129
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients 129
Cetuximab in the treatment of colorectal cancer. 129
ENDOSONOGRAPHIC ASSESSMENT OF RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN PREDICTING SURVIVAL OF ESOPHAGEAL CARCINOMA PATIENTS 128
Totale 15.946
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.153
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.031 0 0 0 19 407 6 19 37 41 53 114 335
2022/20232.666 319 45 37 206 304 205 15 158 1.281 11 44 41
2023/2024993 84 31 48 85 347 127 9 21 8 18 64 151
2024/20253.006 22 92 40 76 476 383 396 275 414 346 233 253
2025/202613.409 484 606 636 678 1.036 7.367 582 766 454 338 215 247
2026/20272.232 141 335 914 842 0 0 0 0 0 0 0 0
Totale 27.638